DiaMedica Therapeutics Inc. - Voting Common Shares, no par value (DMAC)
CUSIP: 25253X207
Q4 2019 13F Holders as of 31 Dec 2019
- Type / Class
- Equity / Voting Common Shares, no par value
- Shares outstanding
- 52,272,727
- Total 13F shares
- 806,746
- Share change
- -150,106
- Total reported value
- $3,914,130
- Price per share
- $4.85
- Number of holders
- 13
- Value change
- -$398,177
- Number of buys
- 7
- Number of sells
- 6
Quarterly Holders Quick Answers
What is CUSIP 25253X207?
CUSIP 25253X207 identifies DMAC - DiaMedica Therapeutics Inc. - Voting Common Shares, no par value in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 25253X207:
Top shareholders of DMAC - DiaMedica Therapeutics Inc. - Voting Common Shares, no par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Manatuck Hill Partners, LLC |
13F
|
Company |
0.52%
|
272,400
|
$564,000 | — | 30 Sep 2019 | |
| Granite Point Capital Management, L.P. |
13F
|
Company |
0.43%
|
227,230
|
$470,000 | — | 30 Sep 2019 | |
| Worth Venture Partners, LLC |
13F
|
Company |
0.27%
|
141,801
|
$294,000 | — | 30 Sep 2019 | |
| WEXFORD CAPITAL LP |
13F
|
Company |
0.17%
|
88,860
|
$184,000 | — | 30 Sep 2019 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.16%
|
81,055
|
$166,000 | — | 30 Sep 2019 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.14%
|
70,919
|
$145,000 | — | 30 Sep 2019 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.05%
|
25,612
|
$53,000 | — | 30 Sep 2019 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.03%
|
15,399
|
$31,000 | — | 30 Sep 2019 | |
| Stonepine Capital Management, LLC |
13F
|
Company |
0.03%
|
13,705
|
$28,000 | — | 30 Sep 2019 | |
| COMMONWEALTH EQUITY SERVICES, LLC |
13F
|
Company |
0.03%
|
13,277
|
$27,000 | — | 30 Sep 2019 | |
| UBS Group AG |
13F
|
Company |
0%
|
2,354
|
$5,000 | — | 30 Sep 2019 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0%
|
2,196
|
$5,000 | — | 30 Sep 2019 | |
| Patriot Financial Group Insurance Agency, LLC |
13F
|
Company |
0%
|
2,000
|
$4,000 | — | 30 Sep 2019 | |
| BANK OF MONTREAL /CAN/ |
13F
|
Company |
0%
|
310
|
$1,000 | — | 30 Sep 2019 |
Institutional Holders of DiaMedica Therapeutics Inc. - Voting Common Shares, no par value (DMAC) as of Q4 2019
As of 31 Dec 2019,
DiaMedica Therapeutics Inc. - Voting Common Shares, no par value (DMAC) was held by
13 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
806,746 shares.
The largest 10 holders included
Manatuck Hill Partners, LLC, Granite Point Capital Management, L.P., Worth Venture Partners, LLC, VANGUARD GROUP INC, MILLENNIUM MANAGEMENT LLC, BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, BLAIR WILLIAM & CO/IL, Federation des caisses Desjardins du Quebec, and Patriot Financial Group Insurance Agency, LLC.
This page lists
13
institutional shareholders reporting positions in this security
for the Q4 2019 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2019 vs Q3 2019 Across Filers
Q3 2019 holders
14
Q4 2019 holders
13
Holder diff
-1
| Investor | Q3 2019 Shares | Q4 2019 Shares | Share Diff | Share Chg % | Q3 2019 Value $ | Q4 2019 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.